Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer
Interventions: DRUG: Atezolizumab|DRUG: Paclitaxel|DRUG: Trastuzumab|DRUG: Pertuzumab
Sponsor: Fox Chase Cancer Center
Collaborators: Genentech, Inc.